Balchem grants CEO Harris 130,000 options; $6.3M value for retention

BALCHEM CORP

130,000 stock options awarded to CEO Ted Harris with grant date Sep 15, 2022; fair value ~$6.3M.
Options split into four tranches at FMV and plus 10%/15%/20% premiums; vest over 5 years.
Bylaws amended to adopt majority voting for director elections, opt out of Maryland control share law.
Board size range confirmed at 3–15; CEO no longer required to be a director; indemnification updated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.